Immunovia Provides Third Update During COVID-19 Pandemic
Extended Emergency Order in Massachusetts Revises Sales Start to Q4 2020 LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”) today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19) pandemic. During these challenging times, Immunovia remains focused on the sales start of the first-to-market test for early diagnosis of pancreatic cancer, IMMray™ PanCan-d. Governor Baker of Massachusetts, USA issued an extended Emergency Order to May 18[th], 2020, resulting in the further closure of certain workplaces and facilities to workers, customers,